SIGA TECHNOLOGIES INC SIGA
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
5/9
Piotroski F — financial health
16.02
Altman Z″ — distress risk · safe
185.2%
Dividend payout · at-risk
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $94.6M | $23.3M | — | — | $198.8M |
| 2024 | $138.7M | $59.2M | — | — | $215.8M |
| 2023 | $139.9M | $68.1M | — | — | $196.9M |
| 2022 | $110.8M | $33.9M | — | — | $170.2M |
| 2021 | $133.7M | $69.5M | — | — | $174.3M |
| 2020 | $125.0M | $56.3M | — | — | $129.8M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Marshall Joseph W III | director | 2026-06-09 | Disposition | 7,235 | $4.39 |
| KEANE JOHN M | director | 2026-06-09 | Option exercise | 24,116 | — |
| KEANE JOHN M | director | 2026-06-09 | Disposition | 7,235 | $4.39 |
| Ford Harold Eugene Jr. | director | 2026-06-09 | Option exercise | 24,116 | — |
| Ford Harold Eugene Jr. | director | 2026-06-09 | Disposition | 7,235 | $4.39 |
| Phillips Holly L. | director | 2026-06-09 | Option exercise | 24,116 | — |
| Phillips Holly L. | director | 2026-06-09 | Disposition | 7,235 | $4.39 |
| Marshall Joseph W III | director | 2026-06-09 | Option exercise | 24,116 | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 16.02 (safe)
- Working capital / assets 0.888
- Retained earnings / assets -0.196
- EBIT / assets 0.108
- Equity / liabilities 9.63
Source: SEC EDGAR filings · CIK 0001010086 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.